Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Grifols SA and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
GRFS · Nasdaq · Healthcare · Drug Manufacturers General
Next earnings: September 28, 2026
$7.35+2.1%Sep 25 close